DÄ internationalArchive47/2007The Use of Mupirocin in the Eradication of Staphylococcus Aureus

Review article

The Use of Mupirocin in the Eradication of Staphylococcus Aureus

Dtsch Arztebl 2007; 104(47): A-3259

Trautmann, M; Stecher, J; Luz, K; Hemmer, W; Hupp, T; Grützner, P A

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

1. Ahmed AOA, Belkum van A, Fahal AH et al.: Nasal carriage of staphylococcus aureus and epidemiology of surgical site infections in a sudanese university hospital. J Clin Microbiol 1998; 36: 3614–8. MEDLINE
2. Borer A, Gilad J, Meydan N et al.: Impact of active monitoring of infection control practices on deep sternal wound infection after open-heart surgery. Ann Thorac Surg 2001; 72: 515–20. MEDLINE
3. Cimochowski GE, Harostock MD, Brown R et al.: Intranasal mupirocin reduces sternal wound infection after open heart surgery in diabetics and nondiabetics. Ann Thorac Surg 2001; 71: 1572–9. MEDLINE
4. Coskun D, Aytac J: Decrease in staphylococcus aureus surgical-site infection rates after orthopedic surgery after intranasal mupirocin ointment (letter). J Hosp Infect 2004; 58: 90–1. MEDLINE
5. Garcia AM, Villa MV, Escudero ME et al.: Uso nasal de la mupirocina para staphylococcus aureus: efeto en portadores y en infecciones nosocomiales. Biomedica 2003 ; 23: 173–9. MEDLINE
6. Gernaat-van der Sluis AJ, Hoogenboom-Verdegaal AM, Edixhoven PJ et al.: Prophylactic mupirocin could reduce orthopedic wound infections: 1044 patients treated with mupirocin compared with 1260 historical controls. Acta Orthop Scand 1998; 69: 412–4. MEDLINE
7. Horiuchi A, Nakayama Y, Kajiyama M et al.: Nasopharyngeal decolonization of methicillin-resistant staphylococcus aureus can reduce PEG peristomal wound infection. Am J Gastroenterol 2006; 101: 274–7. MEDLINE
8. Kallen AJ, Wilson CT, Larson RJ: Perioperative intranasal mupirocin for the prevention of surgical site infections: systematic review of the literature and metaanalysis. Infect Control Hosp Epidemiol 2005; 26: 916–22. MEDLINE
9. Kalmeijer MD, van Nieuwland-Bollen E, Bogaers-Hofman D: Nasal carriage of staphylococcus aureus is a major risk factor for surgical site infections in orthopedic surgery. Infect Control Hosp Epidemiol 2000; 21: 319–23. MEDLINE
10. Kalmeijer MD, Coertjens H, van Nieuwland-Bollen PM et al.: Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study. Clin Infect Dis 2002; 35: 353–8. MEDLINE
11. Kluytmans JA, Mouton JW, Ijzerman EPF: Nasal carriage of staphylococcus aureus as a major risk factor for wound infections after cardiac surgery. J Infect Dis 1995; 171: 216–9. MEDLINE
12. Kluytmans JA, Mouton JW, VandenBergh MF et al.: Reduction of surgical site infections in cardiothoracic surgery by elimination of nasal carriage of staphylococcus aureus. Infect Control Hosp Epidemiol 1996; 17: 780–5. MEDLINE
13. Konvalinka A, Errett L, Fong IW: Impact of treating staphylococcus aureus nasal carriers on wound infections in cardiac surgery. J Hosp Infect 2006; 64: 162–8. MEDLINE
14. Laupland KB, Conly JM: Treatment of staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence based review. Clin Infect Dis 2003; 37: 933–8. MEDLINE
15. Lepelletier D, Perron S, Bizouarn P et al.: Surgical site infection after cardiac surgery: incidence, microbiology, and risk factors. Infect Control Hosp Epidemiol 2005; 26: 466–72. MEDLINE
16. Lidwell O, Lowbury E, Whyte et al.: Bacteria isolated from deep joints sepsis after operation for total hip or knee replacement and the sources of the infections with staphylococcus aureus. J Hosp Infect 1983; 4: 19–29. MEDLINE
17. Lietzau S, Sturmer T, Erb A et al.: Prevalence and determinants of nasal colonization with antibiotic-resistant staphylococcus aureus among unselected patients attending general practitioners in germany. Epidemiol Infect 2004; 132: 655–62. MEDLINE
18. Nicholson MR, Huesman LA: Controlling the usage of intranasal mupirocin does impact the rate of staphylococcus aureus deep sternal wound infections in cardiac surgery patients. Am J Infect Control 2006; 34: 44–8. MEDLINE
19. Perl TM, Cullen JJC, Wenzel RP: Intranasal mupirocin to prevent postoperative staphylococcus aureus infections. N Engl J Med 2002; 346: 1871–7. MEDLINE
20. Perl TM: Prevention of staphylococcus aureus infections among surgical patients: beyond traditional perioperative prophylaxis. Surgery 2003; 134: 10–7. MEDLINE
21. Shrestha NK, Banbury MK, Weber M et al.: Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery. Ann Thorac Surg 2006; 81: 2183–8. MEDLINE
22. Suzuki Y, Kamigaki T, Fujino Y et al.: Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical site infection after digestive surgery. Br J Surg 2003; 90: 1072–5. MEDLINE
23. Usry GW, Johnson L, Weems JJ, Blackhurst D: Process improvement plan for the reduction of sternal site infections among patients undergoing coronary artery bypass graft surgery. Am J Infect Control 2002; 30: 434–6. MEDLINE
24. Wilcox MH, Hall J, Pike H et al.: Use of perioperative mupirocin to prevent methicillin-resistant staphylococcus aureus (MRSA) orthopaedic surgical site infections. J Hosp Infect 2003; 54: 196–201. MEDLINE
25. Yano M, Doki Y, Inoue M: Preoperative intranasal mupirocin ointment significantly reduces postoperative infection with staphylococcus aureus in patients undergoing upper gastrointestinal surgery. Surg Today 2000; 30: 16–21. MEDLINE
e1. Bitkover C, Marcusson E, Ransjö U: Spread of coagulase-negative staphylococci during cardiac operations in a modern operating room. Ann Thorac Surg 2000; 69: 1110–5. MEDLINE
e2. Casewell MW: The nose: an underestimated source of staphylococcus aureus causing wound infection. J Hosp Infect 1998; 40 Suppl B: 3–11. MEDLINE
e3. Davis KA, Stewart JJ, Crouch HK et al.: Methicillin-resistant staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA-infection. Clin Infect Dis 2004; 39: 776–82. MEDLINE
e4. Geubbels EL, Nagelkerke NJ, Mintjes-DeGroot AJ et al.: Reduced risk of surgical site infections through surveillance in a network. Int J Qual Health Care 2006; 18: 127–33. MEDLINE
e5. Giacometti A, Cirioni O, Schimizzi M: Epidemiology and microbiology of surgical wound infections. J Clin Microbiol 2000; 38: 918–22. MEDLINE
e6. Hamasuna R, Besunoh H, Sueyoshi T et al.: Bacteria of preoperative urinary tract infections contaminate the surgical fields develop surgical site infections in urological operations. Int J Urol 2004; 11: 941–7. MEDLINE
e7. Harris AD, Lautenbach E, Perencevich E: A systematic review of quasi experimental study designs in the fields of infection control and antibiotic resistance. Clin Infect Dis 2005; 41: 77–82. MEDLINE
e8. Henkel T, Finlay J: Emergence of resistance during mupirocin treatment: is it a problem in clinical practice? J Chemother 1999; 11: 331–7. MEDLINE
e9. Jakob HG, Borneff-Lipp M, Bach A et al.: The endogenous pathway is a major route for deep sternal wound infection. Eur J Cardiothorac Surg 2000; 17: 154–60. MEDLINE
e10. Kamat AA, Brancazio L, Gibson M: Wound infections in gynecologic surgery. Infect Dis Obstet Gynecol 2000 ; 8: 230–43. MEDLINE
e11. Kluytmans J, van Belkum A, Verbrugh H: Nasal carriage of staphylococus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 1997; 10: 505–20. MEDLINE
e12. Kluytmans JA: Reduction of surgical site infections in major surgery by elimination of nasal carriage of staphylococcus aureus. J Hosp Infect 1998; 40: 525–9.
e13. Kommission für Krankenhaushygiene und Infektionsprävention des Robert-Koch-Instituts. Kommentar zu den „Empfehlungen zur Prävention und Kontrolle von Methicillin-resistenten Staphylococcus aureus-Stämmen in Krankenhäusern und anderen medizinischen Einrichtungen“. Epidemiologisches Bulletin 2004; 46: 396.
e14. Lauwers S, de Smet F: Surgical site infections. Acta Clinica Belgica 1998; 53: 303–9.
e15. Miller MA, Dascal A, Portnoy J, Mendelson J: Development of mupirocin resistance among methicillin-resistant staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17: 811–3. MEDLINE
e16. Pujol M, Pena C, Pallares R et al.: Nosocomial staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 1996; 100: 509–16. MEDLINE
e17. Ruef C, Fanconi S, Nadal D: Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of staphylococcus aureus. J Thorac Cardiovasc Surg 1996; 112: 681–6. MEDLINE
e18. Smyth ET, Emmerson AM: Surgical site infection surveillance. J Hosp Infect 2000; 45: 173–84. MEDLINE
e19. Unemara Y, Ishida Y, Suzuki Y, Yanaga K: Impact of prophylactic mupirocin for radical esophagectomy. J Infect Chemother 2006; 12: 257–63. MEDLINE
e20. von Eiff C, Becker K, Machka K et al.: Nasal carriage as a source of staphylococcus aureus bacteremia. study group. N Engl J Med 2001; 344: 11–6. MEDLINE
e21. Weinstein HJ: The relation between the nasal staphylococcal carrier state and the incidence of postoperative complications. N Engl J Med 1959; 260: 1303–10.
e22. Weiss CA 3rd, Satz CL, Dahms RA et al.: Six years of surgical wound infection surveillance at a tertiary care center: review of the microbiologic and epidemiological aspects of 20 007 wounds. Arch Surg 1999; 134: 1041–8. MEDLINE
e23. Wenzel RP, Perl TM: The significance of nasal carriage of staphylococcus aureus and the incidence of postoperative wound infection. J Hosp Infect 1995: 31: 13–24. MEDLINE
e24. Williams REO, Jevons MP, Shooter RA: Nasal staphylococci and sepsis in hospital patients. Br Med J 1959; 2: 658–63. MEDLINE